Mechanisms for mucosal immunogenicity and adjuvancy of Escherichia coli labile enterotoxin

159Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Escherichia coli labile toxin (LT) was assessed as mucosal immunogen and as adjuvant for tetanus toxoid (TT) in mice. After oral administration of LT, C57BL/6 (H-2b) and BALB/c (H-2(d)) mice were high mucosal and serum antibody responders, while C3H/HeN (H-2(k)) mice were low responders. High responders exhibited mainly serum IgG (including IgG1, IgG2a, and IgG2b), as well as IgM and IgA, while mucosal responses were IgA. Analysis of LT-B-specific CD4+ T helper (Th) cells from Peyer's patches (PP) or from spleen revealed a mixed Th1 (interferon-γ) and Th2 (interleukin-4 and -5) cell pattern. Oral LT given with TT induced TT-specific response patterns identical to LT-B. Analysis of mRNA from TT-specific PP CD4+ Th cells also revealed a mixed Th1- and Th2-type response. Thus, antibody response profiles induced by LT are regulated by both CD4+ Th1 and Th2 cell types.

Cite

CITATION STYLE

APA

Takahashi, I., Marinaro, M., Kiyono, H., Jackson, R. J., Nakagawa, I., Fujihashi, K., … McGhee, J. R. (1996). Mechanisms for mucosal immunogenicity and adjuvancy of Escherichia coli labile enterotoxin. Journal of Infectious Diseases, 173(3), 627–635. https://doi.org/10.1093/infdis/173.3.627

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free